PE69598A1 - Derivados de dibenzo-oxazepina y dioxepina - Google Patents
Derivados de dibenzo-oxazepina y dioxepinaInfo
- Publication number
- PE69598A1 PE69598A1 PE1997000457A PE00045797A PE69598A1 PE 69598 A1 PE69598 A1 PE 69598A1 PE 1997000457 A PE1997000457 A PE 1997000457A PE 00045797 A PE00045797 A PE 00045797A PE 69598 A1 PE69598 A1 PE 69598A1
- Authority
- PE
- Peru
- Prior art keywords
- compounds
- ometoxy
- bromobenzoyl
- choh
- presents
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 4
- 238000002844 melting Methods 0.000 abstract 2
- 230000008018 melting Effects 0.000 abstract 2
- -1 p-BROMOBENZOYL Chemical group 0.000 abstract 2
- 241000228212 Aspergillus Species 0.000 abstract 1
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 206010009944 Colon cancer Diseases 0.000 abstract 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000004092 methylthiomethyl group Chemical group [H]C([H])([H])SC([H])([H])* 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D267/20—[b, f]-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
- C07D321/02—Seven-membered rings
- C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/08—Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Motorcycle And Bicycle Frame (AREA)
- Rehabilitation Tools (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
SE REFIEREN A COMPUESTOS DE FORMULA (I), EN DONDE: R1 Y R2 SON H, ALQUILO INFERIOR O ACILO; "X" ES CO o CHOH; "Y" ES CO o CH2; "Z" ES CO o NH; SIENDO COMPUESTOS (I) PREFERIDOS, EN DONDE: (A) R1 ES H; R2 ES H; "X" E "Y" SON CO; "Z" ES O, QUE PRESENTA UN PUNTO DE FUSION DE 187�C A 188�C, Y SU EPIMERO QUE PRESENTA UN PUNTO DE FUSION DE 198�C A 199�C; (A1) R1 Y R2 SON ACETILO; "X" E "Y" SON CO; "Z" ES O; (A2) R1 ES H; R2 ES p-BROMOBENZOILO; "X" E "Y" SON CO; "Z" ES O; (A3) R1 Y R2 SON p-BROMOBENZOILO; "X" E "Y" SON CO; "Z" ES O; (A4) R1 ES H; R2 ES CH3; "X" E "Y" SON CO; "Z" ES O; (A5) R1 ES (-)OMETOXIO(CF3)FENILACETILO; R2 ES CH3; "X" E "Y" SON CO ; "Z" ES O; (A6) ES COMO A5, PERO R1 ES (+)OMETOXIO(CF3)FENILACETILO; (A7) R1 ES CH2SCH3; R2 ES CH3; "X" E "Y" SON CO; "Z" ES O; (A8) R1 Y R2 SON H; "X" ES CHOH; "Y" ES CO; "Z" ES O; (A9) R1 Y R2 SON H; "X" ES CO; "Y" ES CH2; "Z" ES O; (A10) R1 Y R2 SON H; "X" E "Y" SON CO; "Z" ES NH; Y LOS EPIMEROS DEL A1, A2, A3, A4, A5 Y A6. TAMBIEN SE REFIERE AL PROCESO PARA PRODUCIR LOS COMPUESTOS (I), QUE COMPRENDE CULTIVAR UN MICROORGANISMO DEL GENERO ASPERGILLUS BAJO CONDICIONES AEROBICAS. LOS COMPUESTOS OBTENIDOS SE CONOCEN COMO FUNGARRESTINAS Y ACTUAN INHIBIENDO LA PROLIFERACION DE LINEAS CELULARES TRANSFORMADAS, SIENDO UTILES COMO ANTITUMORALES EN EL CANCER DE MAMA O COLORECTAL, ENTRE OTROS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96109115 | 1996-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE69598A1 true PE69598A1 (es) | 1998-11-14 |
Family
ID=8222857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1997000457A PE69598A1 (es) | 1996-06-07 | 1997-05-30 | Derivados de dibenzo-oxazepina y dioxepina |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US5811420A (es) |
| EP (1) | EP0906295B1 (es) |
| JP (1) | JP3199752B2 (es) |
| KR (1) | KR100300152B1 (es) |
| CN (1) | CN1072650C (es) |
| AT (1) | ATE207471T1 (es) |
| AU (1) | AU725649B2 (es) |
| BR (1) | BR9709773A (es) |
| CA (1) | CA2257422A1 (es) |
| CO (1) | CO4940487A1 (es) |
| CZ (1) | CZ397498A3 (es) |
| DE (1) | DE69707672T2 (es) |
| DK (1) | DK0906295T3 (es) |
| ES (1) | ES2166087T3 (es) |
| HK (1) | HK1019063A1 (es) |
| HR (1) | HRP970313A2 (es) |
| HU (1) | HUP0001792A3 (es) |
| IL (1) | IL127137A0 (es) |
| MA (1) | MA24197A1 (es) |
| NO (1) | NO985685L (es) |
| NZ (1) | NZ332997A (es) |
| PE (1) | PE69598A1 (es) |
| PL (1) | PL330346A1 (es) |
| PT (1) | PT906295E (es) |
| RU (1) | RU2167871C2 (es) |
| TR (1) | TR199802517T2 (es) |
| UY (1) | UY24578A1 (es) |
| WO (1) | WO1997047611A1 (es) |
| YU (1) | YU55898A (es) |
| ZA (1) | ZA974886B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ307399A0 (en) * | 1999-09-24 | 1999-10-21 | Luminis Pty Limited | Cell cycle control |
| CA2404540A1 (en) * | 2002-09-20 | 2004-03-20 | Institut Pasteur | A method for measuring a marker indicative of the exposure of a patient to nicotine; a kit for measuring such a marker |
| US20130203715A1 (en) | 2010-07-20 | 2013-08-08 | Pulmatrix, Inc. | Use of trp channel agonists to treat infections |
| CN109722389B (zh) * | 2017-10-31 | 2021-05-14 | 鲁南新时代生物技术有限公司 | 一种烟曲霉菌液体培养基 |
| CN108165590B (zh) * | 2017-12-20 | 2021-11-23 | 河南科技学院 | 一种烟曲霉发酵产烟曲霉素的培养基及培养方法 |
| WO2022187611A1 (en) * | 2021-03-04 | 2022-09-09 | Lifemine Therapeutics | Cdk inhibitor compounds for use in methods of treatment |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9120640D0 (en) * | 1991-09-27 | 1991-11-06 | Ici Plc | Tricyclic heterocycles |
| US5350763A (en) * | 1993-06-11 | 1994-09-27 | Merck & Co., Inc. | Unguinol and analogs are animal growth permittants |
| JPH0769882A (ja) * | 1993-08-27 | 1995-03-14 | Nippon Paint Co Ltd | エプスタイン−バーウィルス活性化抑制剤 |
| DE69429440T2 (de) * | 1993-10-15 | 2002-08-08 | Schering Corp., Kenilworth | Tricyclische sulfonamide-derivate zur inhibierung der g-protein funktion und fur die bekandlung von proliferativen erkrantungen |
-
1997
- 1997-05-30 DE DE69707672T patent/DE69707672T2/de not_active Expired - Fee Related
- 1997-05-30 PE PE1997000457A patent/PE69598A1/es not_active Application Discontinuation
- 1997-05-30 HU HU0001792A patent/HUP0001792A3/hu unknown
- 1997-05-30 ES ES97927080T patent/ES2166087T3/es not_active Expired - Lifetime
- 1997-05-30 CZ CZ983974A patent/CZ397498A3/cs unknown
- 1997-05-30 IL IL12713797A patent/IL127137A0/xx not_active IP Right Cessation
- 1997-05-30 YU YU55898A patent/YU55898A/sh unknown
- 1997-05-30 CN CN97195242A patent/CN1072650C/zh not_active Expired - Fee Related
- 1997-05-30 DK DK97927080T patent/DK0906295T3/da active
- 1997-05-30 BR BR9709773A patent/BR9709773A/pt not_active Application Discontinuation
- 1997-05-30 KR KR1019980710016A patent/KR100300152B1/ko not_active IP Right Cessation
- 1997-05-30 EP EP97927080A patent/EP0906295B1/en not_active Expired - Lifetime
- 1997-05-30 PL PL97330346A patent/PL330346A1/xx unknown
- 1997-05-30 TR TR1998/02517T patent/TR199802517T2/xx unknown
- 1997-05-30 AU AU31696/97A patent/AU725649B2/en not_active Ceased
- 1997-05-30 CA CA002257422A patent/CA2257422A1/en not_active Abandoned
- 1997-05-30 JP JP50112498A patent/JP3199752B2/ja not_active Expired - Fee Related
- 1997-05-30 PT PT97927080T patent/PT906295E/pt unknown
- 1997-05-30 NZ NZ332997A patent/NZ332997A/xx unknown
- 1997-05-30 RU RU99100107/04A patent/RU2167871C2/ru not_active IP Right Cessation
- 1997-05-30 AT AT97927080T patent/ATE207471T1/de not_active IP Right Cessation
- 1997-05-30 WO PCT/EP1997/002806 patent/WO1997047611A1/en not_active Application Discontinuation
- 1997-06-03 ZA ZA9704886A patent/ZA974886B/xx unknown
- 1997-06-05 CO CO97031203A patent/CO4940487A1/es unknown
- 1997-06-05 UY UY24578A patent/UY24578A1/es unknown
- 1997-06-05 MA MA24647A patent/MA24197A1/fr unknown
- 1997-06-06 US US08/870,798 patent/US5811420A/en not_active Expired - Fee Related
- 1997-06-06 HR HR96109115.4A patent/HRP970313A2/xx not_active Application Discontinuation
-
1998
- 1998-12-04 NO NO985685A patent/NO985685L/no not_active Application Discontinuation
-
1999
- 1999-09-22 HK HK99104107A patent/HK1019063A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9508195D0 (en) | Novel biologically active compounds and compositions,their use and derivation | |
| DK0749432T3 (da) | 9-deoxotaxan-forbindelser | |
| AP2004003103A0 (en) | Controlled synthesis of ziprasidone and compositions thereof | |
| BG106440A (en) | Nitrogen-heterocyclic derivatives as nos inhibitors | |
| HUT67144A (en) | Piperazinyl-and piperidinyl-cyclohexanols and pharraceutical compositions comprising them | |
| IL110660A0 (en) | Phosphonooxymethyl ethers of taxane derivatives | |
| YU13200A (sh) | Postupci i intermedijeri za dobijanje anti-kancernih jedinjenja | |
| BG103310A (en) | Benzonaphthyridins as bronchial therapeutical means | |
| PE69598A1 (es) | Derivados de dibenzo-oxazepina y dioxepina | |
| PT1275389E (pt) | Composições que contêm taxanos em c7 | |
| WO1994019343A3 (en) | Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof | |
| ES2062202T3 (es) | Derivado del indol. | |
| UA27022C2 (uk) | Похідhі карбазолоhу як проміжhі сполуки для отримаhhя оhдаhсетроhу | |
| HUT62585A (en) | Process for producing 6-amino-octahydro-indolizinetriole derivatives and phqrmaceutical compositions comprising same as active ingredient | |
| HK1028046A1 (en) | Intermediates and methods useful in the semisynthesis of paclitaxel and analogs | |
| IL108836A0 (en) | C9 taxane derivatives and pharmaceutical compositions containing them | |
| GR3023757T3 (en) | Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents. | |
| WO2004014294A3 (en) | 4,7-disubstituted indoles and methods of making | |
| UA37239C2 (uk) | Хлорметилдіарилоксирани | |
| DE2963605D1 (en) | Substituted 2-phenylamino-2-imidazolines, their acid addition salts, pharmaceutical compositions containing them and process for their preparation | |
| AU9743598A (en) | Cosmetic products | |
| PL361936A1 (en) | Substituted 4,5-dihydro-1,2,4-triazin-3-ones, 1,2,4-triazin-3-ones, and their use as fungicides and insecticides | |
| AU2910800A (en) | Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines | |
| ES2023759A6 (es) | Procedimiento para la preparacion de nuevos derivados del 1,4-benzodioxano. | |
| NZ234924A (en) | 1,3-oxazine derivatives and antitussive compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |